Not one side effect in humans. Safety is very strong. In 12 months time NyR will be sitting infront of a multi billion dollar license agreement and money pouring all over it. Just like Aptoll. NYR the only drug in the world that protects the heart muscles in heart attacks while preventing sudden cardiac arrest and protecting the brain.
Big pharma deal that CEO talks about if it’s the same as Aptoll on a 200 million upfront payment and 2 billion dollar license agreement we will see $5-$7 dollars a stock.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 22143 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 10.17am 31/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable